|
Tabla 2: Mapa de sensibilidad a aislamientos principales (gram-positivos). |
||||||
|
|
Staphylococcus epidermidis, % N = 25 |
Enterococcus faecalis, % N = 24 |
Enterococcus faecium, % N = 16 |
Staphylococcus aureus, % N = 13 |
Staphylococcus hominis, % N = 8 |
Staphylococcus haemolyticus, % N = 6 |
|
Gentamicina |
52 |
53 |
39 |
83 |
88 |
0 |
|
Tigeciclina |
100 |
100 |
100 |
100 |
100 |
80 |
|
Ceftarolina |
100 |
0 |
0 |
100 |
0 |
100 |
|
Clindamicina |
13 |
0 |
0 |
54 |
0 |
0 |
|
Levofloxacino |
21 |
62 |
38 |
54 |
29 |
0 |
|
Moxifloxacino |
26 |
62 |
71 |
54 |
43 |
0 |
|
Linezolid |
86 |
100 |
87 |
100 |
100 |
83 |
|
Oxacilina |
17 |
50 |
0 |
62 |
0 |
0 |
|
Rifampicina |
92 |
0 |
0 |
92 |
71 |
40 |
|
Tetraciclina |
79 |
30 |
19 |
92 |
86 |
67 |
|
Vancomicina |
96 |
100 |
94 |
100 |
100 |
100 |
|
Daptomicina |
100 |
100 |
0 |
100 |
0 |
100 |
|
Doxiciclina |
67 |
50 |
67 |
100 |
100 |
100 |